|

encorafenib + cetuximab + FOLFIRI Clinical Trials

1 actively recruiting trial

Also known as: FOLFIRI, cetuximab, encorafenib

Pipeline

Phase 2: 1

Top Sponsors

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Indications

  • Colorectal Tumor1
  • Colon Carcinoma1
  • Colon Adenocarcinoma1
  • Colon Neoplasm1
  • Colorectal Adenocarcinoma1

Other1 trial

Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.